The reduced potential of HCC cells to colonize the target organ observed in the presence of MK2206 and IL‐17A could be a consequence of the effect of MK2006 itself on the cell cycle or cell viability and not due to its ability to block signalling cascades activated downstream of IL‐17A. The gene discussed is IL17A; the disease is hepatocellular carcinoma.